Petra Duda

Petra Duda is a highly experienced professional in the field of clinical research and multiple sclerosis, currently serving as Global Development Lead at UCB since April 2020 and Executive Director of Clinical Research at Ra Pharmaceuticals since 2017. With a robust background that includes roles such as Senior Director of Clinical Research at Ra Pharmaceuticals, Medical Director at Sarepta Therapeutics, and Director of Medical Research at Biogen, Petra has a proven track record in advancing neuroimmunological research. Educational credentials include an MD PhD in Medicine and Biology from the University of Bern, complemented by postdoctoral work at Harvard Medical School focused on T cell immunology in multiple sclerosis patients.